GO
Loading...

Vanity Company Not Looking Pretty

Tuesday, 7 Aug 2007 | 7:58 PM ET

Syneron Medical yesterday reported a better-than-expected quarter and raised guidance. Today, much to Cramer’s surprise, the stock is down almost 6%.

Spotlight on Syneron
Mad Money host Jim Cramer takes an in-depth look at Syneron and talks to the company's CEO, Doron Gerstel.

Competitors are disappointing left and right, he said, but this non-invasive medical company, which does everything from hair removal to wrinkle reduction to dental products, had 52% growth in North America and 21% growth internationally. The balance sheet is clear too – no debt and $6.90 per share in cash. Even the pipeline is strong.

So what’s wrong with Syneron , which today sunk $1.48, or 5.9%, to $23.67?

CEO Doron Gerstel said the problem is competition. Traders are looking at the five or six companies that are coming public.

“I think they’re worried about our situation in this market,” he said.

Cramer’s advice: “We wait for the IPOs to happen. We see if it puts more pressure on ELOS. And only then do we buy. It’s too early.”

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
ELOS
---

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.